You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 127 No. 5, May 1971 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on Web of Science (18)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Furosemide in Essential Hypertension

A Statistical Analysis of Three Double-Blind Studies

Lothar Wertheimer, MD; Frank A. Finnerty, Jr., MD; Bernard A. Bercu, MD; Robert H. Hall, PhD

Arch Intern Med. 1971;127(5):934-938.


Abstract

The antihypertensive action of furosemide was evaluated in double-blind studies conducted in three different hospital clinics, by investigators following an identical protocol. The pressure lowering effect of furosemide was compared with that of a placebo in a randomized cross-over study. Both systolic and diastolic pressures were lowered significantly from pretreatment levels in over 50% of patients. No clinically important side effects attributable to furosemide were encountered in this study. Hyperuricemia was encountered in 31 of 44 patients. No significant disturbances of electrolyte balance were noted. Statistical analysis of the pooled data supported the conclusion that furosemide exerts an antihypertensive effect similar to that of other widely used sulfonamide diuretics, and therefore appears to be an effective agent for the treatment of mild to moderate hypertension.



Author Affiliations

New York; Washington, DC; Eloise, Mich; Cincinnati

From the Department of Medicine, New York Medical College Center for Chronic Disease, Bird S. Coler Hospital, Welfare Island, NY (Dr. Wertheimer); Department of Medicine, Georgetown University Medical Division, D. C. General Hospital, Washington, DC (Dr. Finnerty); Department of Medicine University of Michigan Medical School, Wayne County General Hospital, Eloise, Mich (Dr. Bercu); and Hoechst Pharmaceutical Company, Cincinnati (Dr. Hall).


Footnotes

Received for publication May 26, 1970; accepted Oct 15.

Reprint requests to Bird S. Coler Hospital, Welfare Island, New York 10017 (Dr. Wertheimer).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Long-Term Effects of Furosemide and Hydrochlorothiazide in Patients With Essential Hypertension: A Two-Year Comparison of Efficacy and Safety
Finnerty et al.
ANGIOLOGY 1977;28:125-133.
ABSTRACT  

Furosemide and Plasma Renin Activity in Essential Hypertension
Hutcheon and Sandhu
ANGIOLOGY 1976;27:579-586.
 

Malignant Hypertension: Current Modes of Therapy
Dranov et al.
Arch Intern Med 1974;133:791-801.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1971 American Medical Association. All Rights Reserved.